Group 1 - The company Jingwei Hengrun announced on January 14 that Mr. Cao Xuming completed his share reduction plan, reducing a total of 970,000 shares, which accounts for 0.8086% of the company's current total share capital [1] - The share reduction was executed through centralized bidding and block trading methods during the specified reduction period [1] - As of the date of the announcement, the time frame for the relevant share reduction plan has expired [1] Group 2 - Haili Biological's valuation has reportedly decreased by 50% over eight months, despite a previous ninefold increase due to acquisitions [1] - The company's largest client is noted to be a company that has not yet been established, raising questions about the business's operational integrity [1] - The article highlights several unusual circumstances surrounding the company's financial situation and client relationships [1]
经纬恒润:曹旭明减持公司股份97万股,减持计划时间区间已届满